Loading company…
Santaris Pharma develops RNA-targeted therapies for oncology and other disease areas.
Santaris Pharma develops RNA-targeted therapeutics, including candidates for oncology and other therapeutic areas. Founded in 2003 and based in Denmark, it was acquired by Roche in August 2014 for USD 450 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in